Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TJO-083 in Dry Eye Disease
NCT05346783Phase 2Unknown
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Start
- Oct 2021
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
A Phase 2 trial of TJO-083 in dry eye syndrome (DED), sponsored by Taejoon Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
TJO-083
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT05346783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05346783.